|
Volumn 30, Issue 12, 2006, Pages 2132-2135
|
Lessons learned from initial experience with peritonectomy and intra-peritoneal chemotherapy infusion
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
FLUOROURACIL;
MITOMYCIN C;
ABDOMINAL SURGERY;
ADULT;
APPENDIX TUMOR;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER SURVIVAL;
CARCINOMATOUS PERITONITIS;
CLINICAL ARTICLE;
COLON TUMOR;
COMBINATION CHEMOTHERAPY;
CONTINUOUS INFUSION;
CYTOREDUCTIVE SURGERY;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL TUMOR;
HOSPITALIZATION;
HUMAN;
HYPERTHERMIC THERAPY;
INTRAOPERATIVE PERIOD;
MALE;
MORBIDITY;
OPERATION DURATION;
PATIENT MONITORING;
PATIENT SELECTION;
PERIOPERATIVE PERIOD;
PERITONECTOMY;
PERITONEUM METASTASIS;
POSTOPERATIVE CARE;
RETROSPECTIVE STUDY;
REVIEW;
SINGLE DRUG DOSE;
STOMACH CARCINOMA;
STOMACH TUMOR;
SURGICAL MORTALITY;
SURVIVAL RATE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TUBE;
ADULT;
ANTINEOPLASTIC AGENTS;
CARCINOMA;
FEMALE;
HUMANS;
INFUSIONS, PARENTERAL;
MALE;
MIDDLE AGED;
PERITONEAL NEOPLASMS;
PERITONEUM;
RETROSPECTIVE STUDIES;
|
EID: 33845352934
PISSN: 03642313
EISSN: 14322323
Source Type: Journal
DOI: 10.1007/s00268-005-0474-2 Document Type: Review |
Times cited : (12)
|
References (6)
|